Page 130 of 291 · 8,722 total

patent terminated or settled · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Hermes IP Management LLC

· IPR2025-00953

Samsung Electronics and Hermes IP Management have settled their IPR dispute over U.S. Patent 9,613,060 and jointly filed a motion to have the settlement agreement treated as business‑confidential information, effectively terminating the proceeding.

patent · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.

· IPR2025-00934

Samsung challenges a Director Review request by Wilus over its Wi‑Fi 6 patent. The response argues that discretionary denial factors favor referral and that the cited grounds do not merit review, keeping the IPR instituted.

patent · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.

· IPR2025-00934

Samsung seeks to uphold an IPR institution on Wilus’s Wi‑Fi packet‑format patent, while Wilus requests Director Review to overturn the institution, arguing errors on public accessibility, discretionary denial, and claim‑construction inconsistency.

patent denied · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.

· IPR2025-00934

The USPTO denied Samsung's request for Director Review of the institution decisions in several IPRs involving Wilus's patent 11,159,210. The institution decisions remain in effect.

patent denied · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.

· IPR2025-00934

Wilus sought leave to address recent director‑review decisions and submit new evidence in five IPRs, but the Director denied the request, citing policy against inconsistent claim constructions and statutory timing constraints.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00905

Apple and Apex Beam reached a confidential settlement and jointly moved to terminate the IPR over patent 11,917,581 covering UE and base‑station paging technology.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00898

Apple and Apex Beam Technologies entered a settlement that led to the joint termination of sixteen inter partes review proceedings, including IPR2025-00898 covering patent 10,951,271. The Board granted the motion to terminate under 35 U.S.C. § 317.

patent instituted · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00894

Apple’s IPR petition was granted, instituting review of all 20 claims of Apex Beam’s 5G paging patent. The Board found a reasonable likelihood of unpatentability based on prior art You, Liu, and Mallick.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00894

Apple and Apex Beam Technologies jointly moved to terminate sixteen inter‑partes review proceedings after reaching a settlement. The PTAB granted the motion, treating the settlement agreements as confidential.

patent · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Hermes IP Management LLC

· IPR2025-00953

Samsung Electronics and Hermes IP Management have settled their dispute over U.S. Patent 9,613,060 and jointly moved to terminate the inter partes review. The motion relies on 35 U.S.C. § 317(a) and cites public‑policy reasons for settlement.

patent terminated or settled · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Hermes IP Management LLC

· IPR2025-00953

Samsung and Hermes IP Management settled their IPR dispute over U.S. Patent 9,613,060 before the Board instituted a trial. The Board granted the parties' motions to terminate and treated the settlement agreement as confidential.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00898

Apple and Apex Beam have reached a confidential settlement and jointly moved to terminate the IPR concerning Apex Beam’s multi‑antenna transmission patent (U.S. 10,951,271). The motion cites compliance with 35 U.S.C. §317 and argues that termination serves public policy.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00905

Apple and Apex Beam Technologies settled their disputes, leading to the joint termination of sixteen IPRs covering laser‑beam‑steering patents. The Board granted the motion, citing good cause and public‑policy benefits of settlement.

patent terminated or settled · Jan 5, 2025

Google LLC v.Sandpiper CDN, LLC

· IPR2025-00860

Kaifi LLC and Amazon reached a settlement, filing a joint motion to stay court deadlines while they finalize the agreement.

patent terminated or settled · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00894

Apple and Apex Beam have settled their dispute over U.S. Patent 10,462,767 and jointly moved to terminate the inter partes review.

patent terminated or settled · Jan 5, 2025

Docker Inc. v.Intellectual Ventures II LLC

· IPR2025-00840

Docker Inc. and Intellectual Ventures II LLC settled their inter partes review disputes before trial, leading the PTAB to dismiss the IPRs. The settlement covered three patents and the agreements were treated as confidential business information.

patent · Jan 5, 2025

AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.

· IPR2025-00945

Azurity has filed an IPR petition seeking cancellation of all 25 claims of Helsinn’s antiemetic patent (US 8,623,826) on the ground that the claims are obvious over multiple prior‑art references and that the asserted synergy is not unexpected.

patent · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00922

Apple Inc. petitions the PTAB to invalidate claims 1‑20 of Apex Beam’s multi‑antenna transmission patent, asserting obviousness over Liu and Park publications. The petition details a predictable combination of prior‑art teachings and argues against discretionary denial.

patent · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00898

Apple has filed an IPR petition challenging Apex Beam’s 10,951,271 patent covering multi‑antenna transmission, asserting that all 20 claims are obvious over prior‑art disclosures by Kim and Chen.

patent · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00894

Apple has filed an IPR petition challenging Apex Beam’s 2019 patent covering paging methods in LTE/5G networks, asserting that all 20 claims are obvious over prior‑art standards and patents. The petition seeks institution of the review and argues that discretionary denial is unwarranted.

patent · Jan 5, 2025

AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.

· IPR2025-00948

Azurity has filed an IPR petition seeking cancellation of all 23 claims of Helsinn’s U.S. Patent 9,943,515 covering netupitant‑based anti‑emetic regimens, arguing the claims are obvious over prior‑art combinations and lack secondary considerations.

patent · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Hermes IP Management LLC

· IPR2025-00953

Samsung has filed an IPR petition challenging 12 claims of Hermes IP’s ’060 patent covering location‑based services for camera phones, asserting obviousness over multiple prior‑art references.

patent · Jan 5, 2025

AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.

· IPR2025-00947

Azurity petitions to invalidate 39 claims of Helsinn’s anti‑emetic patent, arguing the claimed netupitant/palonosetron regimen is obvious over prior art and lacks any unexpected synergy.

patent · Jan 5, 2025

AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.

· IPR2025-00946

Azurity has filed an IPR petition seeking cancellation of 23 claims of Helsinn’s anti‑emetic patent covering netupitant, palonosetron and dexamethasone regimens. The challenger alleges obviousness over multiple prior‑art references and disputes the asserted unexpected synergy. No decision has been issued yet.

patent · Jan 5, 2025

Apple Inc. v.Apex Beam Technologies LLC

· IPR2025-00905

Apple has filed an IPR petition seeking cancellation of 21 claims of Apex Beam’s paging patent (U.S. 11,917,581). The petition alleges obviousness over Yeo, 3GPP TS 36.304, and Mallick references and argues that discretionary denial is not warranted.

patent · Jan 5, 2025

Google LLC v.Sandpiper CDN, LLC

· IPR2025-00860

Google has petitioned the PTAB to invalidate all 20 claims of Sandpiper CDN’s CDN patent, arguing anticipation by Newton-471 and obviousness over Dilley, Pai, and Wang. The petition stresses favorable institution factors and argues against discretionary denial.

patent · Jan 5, 2025

Samsung Electronics Co. Ltd. et al. v.VB Assets, LLC

· IPR2025-00871

Samsung has filed an IPR petition challenging VB Assets' U.S. Patent 10,510,341, asserting that all 18 claims are obvious over prior‑art combinations of SmartKom/Kobsa and Barbara/Ross. The petition seeks institution of the review.

patent · Jan 5, 2025

Docker Inc. v.Intellectual Ventures II LLC

· IPR2025-00840

Docker has filed an IPR petition against Intellectual Ventures' U.S. Patent 8,332,844 covering a block‑level branching store file system, seeking cancellation of claims 1‑27 on the basis of obviousness over four prior‑art combinations.

patent · Jan 5, 2025

AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.

· IPR2025-00949

Azurity has filed an IPR petition seeking cancellation of all 23 claims of Helsinn’s anti‑emetic patent (US 10,828,297) on the ground that the claims are obvious over standard chemotherapy anti‑emetic regimens. The petition argues the examiner’s reliance on alleged unexpected synergy is unsupported.

patent · Jan 5, 2025

Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.

· IPR2025-00934

Samsung has filed an IPR petition challenging U.S. Patent 11,159,210, asserting that all nine claims are obvious over the 802.11ax draft standard and two earlier patent publications. The petition relies on expert testimony and argues that the Board should not exercise discretionary denial.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →